Copenhagen to get new quantum chip facility
Quantum Foundry Copenhagen and the Novo Nordisk Foundation are building a 5,300m² quantum chip fabrication facility in Copenhagen, aiming to strengthen Europe’s position in the global quantum race.
The facility will develop and scale the advanced manufacturing equipment needed to produce next-generation quantum chips. While Europe has built one of the world’s strongest research environments in quantum science, global leadership in the field will depend not only on scientific breakthroughs but also on the ability to turn them into commercial products at scale, and chip fabrication is a critical part of that process.
Quantum Foundry Copenhagen, owned by the Novo Nordisk Foundation, is a specialized technology company developing proprietary tools, materials, and processes for quantum chip manufacturing. The new facility will combine laboratory space for nanofabrication and testing with ultra-high vacuum manufacturing capabilities, offering wafer fabrication to quantum technology vendors globally on commercial terms.
“Our vision is to become a world-leading quantum chip manufacturer, supplying Europe with advanced, next-generation quantum computing processors and enabling quantum companies to scale production,” says Peter Krogstrup, CEO, Quantum Foundry Copenhagen.
The foundry builds on the Novo Nordisk Foundation’s long-term commitment to quantum technologies, which now totals more than DKK 2.9 billion (EUR 390 million), including the Novo Nordisk Foundation Quantum Computing Programme at the Niels Bohr Institute, University of Copenhagen. That program aims to develop Denmark’s first fully functional fault-tolerant quantum computer before 2034, and the new facility will work closely with it, linking frontier research, talent development, and industrial manufacturing.
“Quantum Foundry Copenhagen is an important part of our ambition, helping connect investments in research with the industrial capabilities needed to support Europe’s ability to transform quantum breakthroughs into technologies that can benefit society,” says Professor Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation.
The facility is expected to open in 2027.
Published: September 10, 2026
